Trust Takes Centre Stage as Musk-OpenAI Trial Heads to the Jury
Closing arguments end today and the jury must decide whether Sam Altman's Congressional framing of his OpenAI exposure passes a basic credibility test.
The News
Closing arguments wrapped this week in Elon Musk's lawsuit against OpenAI, and the jury began deliberations as the trial concluded today. The case has narrowed to a question the original founding documents never anticipated: whether Sam Altman, OpenAI's chief executive, is a witness the jury can trust.
The most-watched cross-examination revisited Altman's earlier testimony before the United States Congress, where he stated he had no equity in OpenAI. Steve Molo, Musk's lead counsel, pressed Altman on a more complicated picture: an indirect stake through Y Combinator, the accelerator he once ran, which had previously written a cheque into OpenAI as a passive investor.
Altman's defence rested on the idea that any informed listener should know what passive limited-partner exposure to a venture fund actually means. Molo countered that members of Congress could not reasonably parse fund-level beneficial ownership on the fly.
Why It Matters
The narrow legal claim is whether OpenAI breached founding commitments when it migrated towards its current for-profit posture, including the recapitalisation that closed in October 2025. The broader argument the plaintiff has tried to land is that Altman's reliability as a fiduciary cannot be separated from his reliability as a witness, and that the boardroom shake-up insiders now call the Blip exposed governance weaknesses the new structure has not actually closed off.
The last time a Silicon Valley founder of comparable profile faced a credibility-on-trial moment of this scale, it was Musk himself in the 2018 funding-secured securities case. That dispute was nominally about a tweet but ended up being about whether courts could rely on what tech founders said in public. Eight years on, the same question is back, only the defendant has swapped sides.
Indian Angle
The Altman defence, that a passive limited-partner interest in a venture fund need not surface as direct equity, would not survive Indian disclosure standards. The Securities and Exchange Board of India treats indirect beneficial ownership through pooled vehicles as reportable for listed entities, and its beneficial-owner rules require lookthrough to natural persons holding 10 per cent or more. Founders going public on Indian exchanges must surface fund-level exposures their American counterparts have rarely had to itemise.
This matters for the frontier-model camp at home. Sarvam, Krutrim, and the wider IndiaAI Mission ecosystem are moving towards capital structures that will eventually invite public-market scrutiny. The trial is a live preview of what happens when nonprofit-to-commercial conversions are litigated after the fact, and Indian boards drafting bylaws today have a short window to design governance that does not later need a courtroom to clarify it.
There is also a regulatory read for MeitY and the draft Digital India Act. India has signalled that AI accountability will sit closer to corporate law than to a standalone AI statute of the kind Europe has built, and this trial reinforces that instinct.
FAQ
When does the jury rule?
Deliberations began after closing arguments ended today, 17 May 2026. A verdict could land within days or stretch into next week depending on the jury's pace.
How does this compare to Musk's 2018 securities trial?
Both turned on whether a tech founder's public statements can be relied upon. In 2018 Musk was the defendant over the funding-secured tweet; in 2026 he is the plaintiff arguing Altman's words to Congress fail the same trust test.
What does this mean for Indian AI founders?
SEBI already requires lookthrough disclosure of indirect equity through pooled funds, so an Altman-style framing would not survive an Indian prospectus review. Founders building Sarvam, Krutrim, and the next wave of frontier labs should assume any future IPO is read against this standard.
Where can I read the original coverage?
TechCrunch's reporting on the closing-week testimony is linked in the attribution paragraph below.
This story was reported by TechCrunch. Read the full original coverage at TechCrunch.